Examinant per Autoria "Domene Ochoa, Sandra"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert ATP bioluminescence assay to evaluate antibiotic combinations against extensively drug-resistant (XDR) Pseudomonas aeruginosa(American Society for Microbiology, 2022) Puig-Collderram, Berta; Domene Ochoa, Sandra; Salvà-Comas, Maria; Milagro Montero, Maria; Duran Jordà, Xavier, 1974-; González, Juan Ramón; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo; Padilla, Eduardo; Segura, Concepción; Prim, Núria
Ítem Accés Obert Colistin plus meropenem combination is synergistic in vitro Aagainst extensively drug-resistant pseudomonas aeruginosa, including high-risk clones(Elsevier, 2019) Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; VanScoy, Brian; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Segura, Concepción; Pomar, Virginia; Rivera, Alba; Grau Cerrato, Santiago; Ambrose, Paul G.; Oliver, Antonio; Horcajada Gallego, Juan Pablo
Ítem Accés Obert Comparison of Ceftolozane/Tazobactam infusion regimens in a hollow-fiber infection model against extensively drug-resistant pseudomonas aeruginosa isolates(ASM Press, 2022) Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; López Montesinos, Inmaculada; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Ferrer Alapont, Lorena; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo
Ítem Accés Obert Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model(Nature Research, 2021) Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque Pardos, Sònia; Sorlí, Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Ferrer Alapont, Lorena; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo
Ítem Accés Obert Suboptimal concentrations of ceftazidime/avibactam (CAZ-AVI) may select for CAZ-AVI resistance in extensively drug-resistant pseudomonas aeruginosa. in vivo and In vitro evidence(MDPI, 2022) López Montesinos, Inmaculada; Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Echeverría Esnal, Daniel; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Luque Pardos, Sònia; Padilla, Eduardo; Prim, Núria; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo
Ítem Accés Obert Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa: insights from the hollow-fiber infection model(Taylor & Francis, 2024) Montero, Maria Milagro; Domene Ochoa, Sandra; Prim, Núria; Ferola, Eliana; López-Causapé, Carla; Echeverría Esnal, Daniel; Ampuero Morisaki, Mario F.; Vega Toribio, Victoria; Sorlí, Luisa; Luque Pardos, Sònia; Padilla, Eduardo; Oliver, Antonio; Horcajada Gallego, Juan Pablo
Ítem Accés Obert Time-kill evaluation of antibiotic combinations containing ceftazidime-avibactam against extensively drug-resistant Pseudomonas aeruginosa and their potential role against ceftazidime-avibactam-resistant isolates(American Society for Microbiology, 2021) Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque, Sonia; Sorlí, Luisa; Campillo Ambrós, Núria; López Montesinos, Inmaculada; Padilla, Eduardo; Prim, Núria; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo